Alfredo Pascual headshot
EMAIL: [email protected]
PHONE: 720.213.5971

Alfredo Pascual

Based in Germany, Alfredo specializes in international cannabis markets and regulations, drawing upon his extensive academic background in business and public policy. He founded Transnational Cannabis, a consultancy firm that focused on cannabis regulatory frameworks in Europe and Latin America. Previously, he did business development for ICC Labs with a primary focus on developing expansion opportunities internationally.

Czech medical cannabis sales surge, but market remains small

The Czech market for medical cannabis flower quadrupled last year compared to 2019, according to data published by the State Agency for Medical Cannabis. However, the market remains very small. In 2020, roughly 68 kilograms (150 pounds) of medical cannabis flower was sold to patients in Czech pharmacies, compared with 17 kilograms the year before, […]

Read More

German entrepreneurs find revenue opportunities in private cannabis market

As public health-insurance payouts for medical cannabis in Germany stagnate, entrepreneurs are focusing instead on the private health-care sector, where medical consultations and marijuana is paid for directly by patients. Although Germany is often touted as an attractive market because statutory health insurers are expected to cover the cost of medical marijuana, opportunities in the […]

Read More

Denmark medical cannabis sales post a positive quarter thanks to Epidiolex

Sales of medical marijuana in Denmark posted healthy gains in the third quarter of 2020, coinciding with the launch of GW Pharmaceuticals’ cannabis drug Epidiolex. Overall sales of all medial cannabis products grew from about 13 million Danish Krones ($2 million) in the second quarter to almost 16 million Danish Krones in the third quarter, […]

Read More

Polish medical cannabis market growing rapidly but remains very small

The Polish medical cannabis market is growing rapidly, with imports through August 2020 more than doubling compared to 2019, Marijuana Business Daily has learned. This is believed to be the first time that accurate and updated import data about the Polish medical marijuana market has been publicly available. Access to aggregate market data measuring the […]

Read More

Survey: Majority in Germany still opposes adult-use cannabis legalization

A slim majority of eligible voters in Germany opposes legalizing recreational marijuana, according to a new poll. The results come from a survey conducted in December by Infratest dimap – one of the leading polling agencies and research institutes in Germany – for the advocacy group Hanfverband. The survey, along with a recent vote in […]

Read More

Australian medical cannabis available in German pharmacies for first time

Flower and extracts produced in Australia by two different companies are now available in the German medical cannabis market for the first time, Marijuana Business Daily has learned. The flower, grown by New South Wales-based Australian Natural Therapeutics Group (ANTG), was imported and batch-released by Cologne-based Cannamedical. Cannamedical exclusively sells it to German pharmacies under the […]

Read More

European cannabis producer raises $20 million

Emmac Life Sciences, a European vertically integrated cannabis producer, said it raised 15 million pounds ($20 million) via an issue of convertible loan notes. The Dec. 16 issue “saw strong support from existing shareholders, with Measure 8 Venture Partners, Emmac’s largest existing cash investor, leading the round with a significant investment,” according to a news […]

Read More

Colombian agency recommends allowing cannabis flower exports

The Colombian government may reconsider its ban on medical cannabis flower exports for commercial purposes. A recent letter by the Superintendency of Industry and Commerce (SIC) – a government agency that promotes fair business practices – to the Ministry of Health recommended the country modify current regulations and allow flower exports. This is the first […]

Read More

Insurance-covered medical cannabis reimbursements decline again in Germany

Public health insurance reimbursements for cannabis in Germany have fallen for the second straight quarter. Unless this drop is being offset by an increase in private prescriptions, it means that total sales of medical cannabis in Germany – Europe’s largest market – are decreasing. (Data for private prescriptions is not available.) It is the first […]

Read More

Uruguay completes another large export of high-THC flower to Portugal

Uruguay-based Fotmer completed another large export of high-THC flower to Portugal at the end of November, according to Uruguayan customs records viewed by Marijuana Business Daily. The company declared two exports, each with a value of almost $1.3 million, on Nov. 24 and Nov. 25, respectively. The new shipments are further proof that exporting flower […]

Read More